AFNAS
TEVA icon

American Financial Network Advisory Services’s Teva Pharmaceuticals TEVA Stock Holding History

American Financial Network Advisory Services’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,628
Closed -$69K – 540
2017
Q4 		$69K Sell
3,628
-2,373
-40% -$35.7K 0.03% 308
2017
Q3 		$106K Buy
+6,001
New +$135K 0.05% 267

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

American Financial Network Advisory Services's TEVA Position: Q1 2018 in Review

American Financial Network Advisory Services sold out of Teva Pharmaceuticals (TEVA) in Q1 2018, closing a stake of 3,628 shares — an estimated $69K sold.

American Financial Network Advisory Services first reported a position in TEVA in Q3 2017 and held it in 2 quarters. The position peaked at $106K in Q3 2017. 506 funds tracked by Wall St. Rank hold TEVA as of Q1 2018.

  • American Financial Network Advisory Services reported no remaining Teva Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • American Financial Network Advisory Services sold 3,628 Teva Pharmaceuticals shares in Q1 2018, an estimated $69K.
  • American Financial Network Advisory Services first reported a position in Teva Pharmaceuticals in Q3 2017 and held it in 2 quarters.
  • American Financial Network Advisory Services's Teva Pharmaceuticals position peaked at $106K in Q3 2017.
  • 506 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2018.

Based on American Financial Network Advisory Services's 13F filing for Q1 2018, filed 15 May 2018.